Announcement
02 Feb 2021
In February 2021, the Canadian government allocated CAD 25.1 million for the development and production of ribonucleic acid vaccines and future genetic medicines.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
02 Feb 2021
Revocation date:
No revocation date
On 2 February 2021, Precision NanoSystems announced securing CAD 25.1 million (USD 20 million) from the government to establish a biomanufacturing center to produce ribonucleic acid vaccines and fu...
18 May 2021
Canada: Government announces funding for a Canadian biomanufacturing company
02 Feb 2021
Canada: Government provided funding for the advancement of monoclonal antibody therapy for acute respiratory distress syndrome (COVID-19)
22 Oct 2020
Canada: Precision NanoSystems secures funding from the government to develop a COVID-19 mRNA vaccine
23 Mar 2020
Canada: Government allocates CAD 792 million for the development and production of medical countermeasures to COVID-19
See all
This state act is not part of any Thread yet.